Health Policy Affairs

As part of efforts to improve outcomes and prove that IR therapies can be first-line solutions, SIR, with support of its corporate partners, is moving to the next phase of the VIRTEX clinical data registry and analytics platform. The platform will be built and the first 10 pilot sites brought onboard within the next year, with the goal of bringing on an additional 20 plus sites over the following year.

When this is fully operational, VIRTEX will provide high-quality IR data to track quality and outcomes; compare and evaluate the effectiveness of different treatments and approaches; monitor the safety and effectiveness of equipment and devices; drive quality payment initiatives; advocate for reimbursement, coverage, and access; and demonstrate the value of IR to key stakeholders.